PC-22576 |
Empagliflozin
SGLT2 inhibitor
|
Empagliflozin (BI-10773) is a potent, selective sodium glucose cotransporter-2 (SGLT-2) inhibitor with IC50 of 3.1 nM (hSGLT-2), has a high degree of selectivity over SGLT-1, 4, 5 and 6, has potential for the oral treatment of type 2 diabetes mellitus (T2DM). |